{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:37:14Z","timestamp":1778917034547,"version":"3.51.4"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The fibrosis-4 (FIB4) index, a simple, noninvasive marker used for hepatic diseases, represents adverse outcomes. The aim of the present study was to evaluate whether the FIB4 index can predict adverse outcomes in patients with ST-elevation myocardial infarction (STEMI).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We investigated patients with STEMI who underwent primary percutaneous coronary intervention (PCI) and were alive at discharge. The cut-off FIB4 index at discharge was investigated using the survival classification and regression tree (CART) model to predict adverse outcomes. The primary outcome was all-cause mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Between January 2006 and December 2018, 1354 patients with STEMI (median age, 68\u2005years; men, 76.1%) were investigated. The median value of the FIB4 index was 1.21 (0.84\u20131.78). The CART model divided the study population into low (FIB4 index &lt;0.945; <jats:italic toggle=\"yes\">n<\/jats:italic>\u2005=\u2005435), intermediate (0.945\u2005\u2264\u2005FIB4 index\u2005&lt;\u20052.185; <jats:italic toggle=\"yes\">n<\/jats:italic>\u2005=\u2005692), and high (FIB4 index \u22652.185; <jats:italic toggle=\"yes\">n<\/jats:italic>\u2005=\u2005227) groups based on the significant predictive values for all-cause death. During a median follow-up period of 4.3\u2005years, all-cause death occurred in 208 patients (15.4%). The Kaplan\u2013Meier analysis showed a significant increase in mortality with higher FIB4 index values (log-rank, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001). The multivariate Cox regression model revealed that the FIB4 index was an independent risk predictor for all-cause death in patients with STEMI [low group as reference vs. intermediate group, hazard ratio: 1.975; 95% confidence interval (CI): 1.166\u20133.346; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.011 and vs. high group, hazard ratio: 4.633; 95% CI: 2.549\u20138.418; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001].<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The FIB4 index was associated with the risk of all-cause mortality in patients with STEMI who underwent primary PCI.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000001431","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T11:00:13Z","timestamp":1728298813000},"page":"99-107","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Impact of the fibrosis-4 index in patients with ST-elevated myocardial infarction"],"prefix":"10.1097","volume":"36","author":[{"given":"Naoki","family":"Shibata","sequence":"first","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki"},{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Toyoda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Kanzaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Miyazawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Shimojo","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuma","family":"Ohi","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoshito","family":"Karasawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itsuro","family":"Morishima","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"key":"R1-20250130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1253\/circj.CJ-09-0619","article-title":"Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: report from the MIYAGI-AMI Registry Study.","volume":"74","author":"Takii","year":"2010","journal-title":"Circ J"},{"key":"R2-20250130","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1253\/circj.CJ-22-0241","article-title":"Clinical characteristics and outcomes of patients presenting with acute myocardial infarction without cardiogenic shock.","volume":"86","author":"Okamoto","year":"2022","journal-title":"Circ J"},{"key":"R3-20250130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12928-021-00829-9","article-title":"CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022.","volume":"37","author":"Ozaki","year":"2022","journal-title":"Cardiovasc Interv Ther"},{"key":"R4-20250130","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.amjcard.2019.12.034","article-title":"Impact of hyperglycemia on long-term outcome in patients with ST-segment elevation myocardial infarction.","volume":"125","author":"Kojima","year":"2020","journal-title":"Am J Cardiol"},{"key":"R5-20250130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-230X-12-2","article-title":"Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population.","volume":"12","author":"Sumida","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"R6-20250130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest.","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"R7-20250130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/jgh.14448","article-title":"Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients.","volume":"34","author":"Ito","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"R8-20250130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/14397595.2018.1558760","article-title":"Fibrosis-4 index at diagnosis can predict all-cause mortality in patients with rheumatoid arthritis: a retrospective monocentric study.","volume":"30","author":"Kim","year":"2020","journal-title":"Mod Rheumatol"},{"key":"R9-20250130","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijcard.2020.09.056","article-title":"Impact of predictive value of Fibrosis-4 index in patients hospitalized for acute heart failure.","volume":"324","author":"Shibata","year":"2021","journal-title":"Int J Cardiol"},{"key":"R10-20250130","first-page":"1082","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.","volume":"70","author":"Ibanez","year":"2017","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"R11-20250130","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM198504043121437","article-title":"The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.","volume":"312","year":"1985","journal-title":"N Engl J Med"},{"key":"R12-20250130","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R13-20250130","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/jama.293.5.572","article-title":"Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis.","volume":"293","author":"Fonarow","year":"2005","journal-title":"JAMA"},{"key":"R14-20250130","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.amjcard.2017.07.107","article-title":"Effect of nonalcoholic fatty liver disease on in-hospital and long-term outcomes in patients with ST-segment elevation myocardial infarction.","volume":"120","author":"Keskin","year":"2017","journal-title":"Am J Cardiol"},{"key":"R15-20250130","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.3390\/ijerph18136980","article-title":"The association between decreased kidney function and FIB-4 index value, as indirect liver fibrosis indicator, in middle-aged and older subjects.","volume":"18","author":"Kotoku","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"R16-20250130","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2014.05.019","article-title":"CKD and nonalcoholic fatty liver disease.","volume":"64","author":"Targher","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R17-20250130","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12872-018-0919-9","article-title":"Outcomes of STEMI patients with chronic kidney disease treated with percutaneous coronary intervention: the Malaysian National Cardiovascular Disease Database \u2013 Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014.","volume":"18","author":"Ismail","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"R18-20250130","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/hep.21303","article-title":"Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management.","volume":"44","author":"Caldwell","year":"2006","journal-title":"Hepatology"},{"key":"R19-20250130","doi-asserted-by":"crossref","first-page":"e007571","DOI":"10.1161\/CIRCINTERVENTIONS.118.007571","article-title":"Art and science in registry studies of anemia and myocardial infarction.","volume":"11","author":"Dauerman","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"R20-20250130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12072-021-10167-w","article-title":"Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease.","volume":"15","author":"Jin","year":"2021","journal-title":"Hepatol Int"},{"key":"R21-20250130","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.amjcard.2016.07.022","article-title":"One-year outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction with varying quantities of coronary artery calcium (from a 13-year registry).","volume":"118","author":"Vaduganathan","year":"2016","journal-title":"Am J Cardiol"},{"key":"R22-20250130","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1093\/eurheartj\/eht246","article-title":"Interactions of the heart and the liver.","volume":"34","author":"Moller","year":"2013","journal-title":"Eur Heart J"},{"key":"R23-20250130","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.amjcard.2013.10.018","article-title":"Usefulness of transient elastography for noninvasive and reliable estimation of right-sided filling pressure in heart failure.","volume":"113","author":"Taniguchi","year":"2014","journal-title":"Am J Cardiol"},{"key":"R24-20250130","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/hep.29285","article-title":"FIB-4 stage of liver fibrosis predicts incident heart failure among HIV-infected and uninfected patients.","volume":"66","author":"So-Armah","year":"2017","journal-title":"Hepatology"},{"key":"R25-20250130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jacc.2008.08.067","article-title":"Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction.","volume":"53","author":"Ezekowitz","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R26-20250130","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"R27-20250130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.atherosclerosis.2020.03.010","article-title":"Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease.","volume":"299","author":"Chen","year":"2020","journal-title":"Atherosclerosis"},{"key":"R28-20250130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12872-021-01862-5","article-title":"The prognostic value of MELD-XI in elderly patients with ST-segment elevation myocardial infarction: an observational study.","volume":"21","author":"He","year":"2021","journal-title":"BMC Cardiovasc Disord"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001431","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T11:02:26Z","timestamp":1738234946000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001431","relation":{},"ISSN":["0954-6928","1473-5830"],"issn-type":[{"value":"0954-6928","type":"print"},{"value":"1473-5830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,8]]}}}